A special sub-committee was appointed Monday to look at legislation that would increase transparency on prescription drug costs and give the state Department of Insurance more regulatory control over pharmacy benefits managers.
Please enter your User Name and Password to view the rest of this subscriber-only story. If you are unable to login, your account may have expired. Please contact James Online if you have any problems.
